Treatment of ectopic pregnancies of participants with vinorelbine tablets.
- Conditions
- ECTOPIC PREGNANCYReproductive Health and Childbirth - Other reproductive health and childbirth disorders
- Registration Number
- ACTRN12617001118392
- Lead Sponsor
- orth Shore Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 20
•Aged 18-50 years old
•English speaking
•Able to provide informed consent to participate
•A diagnosis of a tubal ectopic pregnancy on transvaginal ultrasound
•A stable ectopic pregnancy (no evidence of bleeding or rupture)
•A pre-treatment serum Human Chorionic Gonadotrophin (hCG) level of 1,000 – 3,000 IU/L
•Adnexal mass less than or equal to 3.0 cm, with no fetal cardiac activity
•Unable to provide informed consent to participate
•A multiple pregnancy
•Contraindication(s) to vinorelbine or to medical management of ectopic pregnancy
•Immunodeficiency disorder(s)
•A current malignancy
•Received chemotherapy or radiation therapy in the previous five years
•Concomitant disease which could significantly impair gastric absorption (Inflammatory bowel disease, coeliac, etc.)
•History of surgical resection of the stomach/small bowel
•Breastfeeding
•Hepatic impairment, renal impairment, or haematological toxicity
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method